查询最新产品信息,请浏览

Recombinant Human TRAIL/TNFSF10/CD253 (Arg115-Gly281) (C022)

目录 规格 价格
【TNFSF10/TRAIL产品说明】:
Recombinant Human TNF-Related Apoptosis-Inducing Ligand is produced by our E.coli expression system and the target gene encoding Arg115-Gly281 is expressed.
【TNFSF10/TRAIL质量控制】:
Measured by the cytolysis of murine L929 cells in the presence of Actinomycin D.
ED50 is less than 2 ng/ml. Specific Activity of 5.0 x 10^6 IU/mg.
Greater than 95% as determined by reducing SDS-PAGE.
【TNFSF10/TRAIL制剂】:
Lyophilized
【TNFSF10/TRAIL保存】:
Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months.
【TNFSF10/TRAIL复溶】:
Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100 μg/ml.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
【关于TNFSF10/TRAIL】:
Human TNFSF10 is a type II transmembrane protein with an intracellular N-terminus and a ‘TNF homology domain’ (THD) at the extracellular C terminus. TNFSF10 can interact with several distinct receptors. Two of these receptors that belongs to TNFR superfamily, DR4 (TRAIL-R1) and DR5 (TRAIL-R2/TRICK2), are plasma membrane proteins containing intracellular death domains essential for activating apoptosis. TNFSF10 is promising for cancer therapy because it is cytotoxic and activates apoptosis in the majority of malignant cells, but not in normal cells.
For research use ONLY.